Prostate cancer
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Patients who underwent dynamic contrast-enhanced, T2-weighted, and diffusion-weighted prostate MRI at our institution between March 2013 and November 2023.
Exclusion criteria
Exclusion criteria: Patients who refused secondary use of information at the time of informed consent Patients who requested that their information not be used during the opt-out period
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Validity of blood circulation parameters derived from data with frame number reduction | — |
Countries
Japan
Contacts
National Institutes for Quantum Science and Technology Department of Molecular Imaging and Theranostics